Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs etomidate sedation in elderly patients undergoing painless gastroscopy
ChiCTR2300071790Phase 4Not yet recruiting
- Sponsor
- Dazhou Central Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Remimazolam + remifentanil arm with Etomidate + remifentanil arm (2 arms). Primary endpoints: Blood pressure and Respiratory depression. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
remimazolametomidate
Beyond the preview
Go deeper on ChiCTR2300071790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071790.